StockData
Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO) stock

CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$12.40−0.64 (-4.91%)

Close on Nov 18, 2026Market cap $460.58MP/E –Yield –

Crescent Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Crescent Biopharma's price to sales ratio was 430.9× on Feb 29, 2016.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2016Feb 29, 2016430.9×−43.2
2014Apr 30, 2014474.1×–

More Crescent Biopharma figures

See a number that looks wrong?